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Abstract
Introduction Establishing robust reference intervals
for clinical procedures has received much attention
from international clinical laboratories, with approved
guidelines. Physiological measurement laboratories
have given this topic less attention; however, most of
the principles are transferable.
Methods Herein, we summarise those principles and
expand them to cover bilateral measurements and one-
tailed reference intervals, which are common issues
for those interpreting clinical visual electrophysiology
tests such as electroretinograms (ERGs), visual
evoked potentials (VEPs) and electrooculograms
(EOGs).
Results The gold standard process of establishing
and defining reference intervals, which are adequately
reliable, entails collecting data from a minimum of
120 suitable reference individuals for each partition
(e.g. sex, age) and defining limits with nonparametric
methods. Parametric techniques may be used under
some conditions. A brief outline of methods for
defining reference limits from patient data (indirect
sampling) is given. Reference intervals established
elsewhere, or with older protocols, can be transferred
or verified with as few as 40 and 20 suitable reference
individuals, respectively. Consideration is given to
small numbers of reference subjects, interpretation of
serial measurements using subject-based reference
values, multidimensional reference regions and age-
dependent reference values. Bilateral measurements,
despite their correlation, can be used to improve
reference intervals although additional care is required
in computing the confidence in the reference interval
or the reference interval itself when bilateral mea-
surements are only available from some of subjects.
Discussion Good quality reference limits minimise
false-positive and false-negative results, thereby max-
imising the clinical utility and patient benefit. Quality
indicators include using appropriately sized reference
datasets with appropriate numerical handling for
reporting; using subject-based reference limits where
appropriate; and limiting tests for each patient to only
those which are clinically indicated, independent and
highly discriminating.
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Introduction
Reference1 values describe the diversity observed in
parameters measured from a group of individuals
representing some healthy population. Improved
diagnostic quality results from using reference values
garnered from an adequately sized sample of appro-
priate reference individuals. This process has been the
subject of extensive international cooperative work in
the fields of laboratory medicine [2–5], and human
biometrics such as height and weight [6] have received
some attention in other areas of clinical measurement
[7, 8], but less so in clinical electrophysiology of
vision.
The International Society for Clinical Electrophys-
iology of Vision (ISCEV) standards [9–13] and
guidelines [14, 15] state the need for reference values,
but it is not within the scope of such documents to
provide detail on the process. Similarly, whilst some
medical devices for visual electrophysiology hold in-
built reference data, techniques for verifying
their suitability for a patient population may not be
included. The purpose of this work is to collate
expertise from other clinical scientific areas as well as
our own computational studies and present a guide to
reference values relevant for those undertaking or
interpreting clinical visual electrophysiology tests.
This work is also pertinent to other clinical measure-
ments on bilateral systems (e.g. hearing, nerve
conduction) where intra-subject correlation needs to
be considered.
Typically, a reference interval for a single param-
eter includes 95% of its reference values. This 95%
figure may be based on the 5% significance level,
widely used since the early twentieth century, and
selected on the basis of convenience for judging the
significance of a deviation [16]. More stringent criteria
such as a 99.8% reference range have been proposed
[17], but are not widely used nor included in any
consensus guidelines. The use of a 95% reference
range in reporting clinical test results means that any
single test parameter has a 1 in 20 chance of being
classified as abnormal when no abnormality exits.
When multiple parameters per test (e.g. a- and b-wave
amplitudes and peak times) are analysed, or when
multiple tests (e.g. full-field ERG, pattern VEP,
pattern ERG) are conducted, the chance of any false-
positive finding rises, albeit related to the extent of
independence of test parameters [18–20]. Reference
limits can be adjusted to reduce this risk (see section
Adjusting for multiple measurements); however, the
correlation between the measures must be known. It is
advisable to limit electrophysiology tests to only those
clinically indicated—preferably both independent and
highly discriminating—rather than conducting a stan-
dard battery of tests on every patient. This reduces
false-positive findings [21], limits additional unnec-
essary testing, reduces patient risk from investigations
or therapeutic interventions, reduces patient anxiety
and reduces resource wastage in health care [20].
The following terminology has been established for
the subject of reference values and is endorsed by the
World Health Organization [2]:
• Reference individual—a subject who meets the
inclusion criteria.
• Reference population—the group comprising all
reference individuals who exist, usually an
unknown quantity.
• Reference sample group—the group of reference
individuals selected, usually non-randomly, to
represent the reference population.
1 The term ‘normal’ (or ‘normative’) is obsolete because of lack
of scientific clarity due to its triple meaning in the English
language (clinically healthy; statistically Gaussian; popularly
connoting conventional). There also is flawed circular logic
inherent in equating a ‘normal’ person with a person free from
disease, while disease is diagnosed based on measurable
characteristics of ‘normal’ individuals. Finally, the implication
that an individual is ‘abnormal’ should a measurement lie
outside certain limits is pejorative [1].
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• Reference value—value of a test parameter mea-
sured from a reference individual (Fig. 1).
• Reference distribution—the frequency of all ref-
erence values (Fig. 1). Often this distribution
cannot be described by a single mathematical
function. It is relatively rare to find a Gaussian
distribution, so defining reference limits as the
mean ± some standard deviations of the reference
values is rarely appropriate and risks systematic
misclassifications (see Parametric method).
• Reference limit—a value derived mathematically
from the reference distribution, defined such that a
stated fraction (e.g. 2.5%) of the reference values
lies above or below it (Fig. 1).
• Reference interval—the interval considered as
healthy, which for two-tailed limits is the interval
between and including the two reference limits
(Fig. 1) or for one-tailed reference limits, the
values equal to or above/below the one reference
limit.
Commercial software and freeware [22] are avail-
able to undertake most or all of the processes described
here. Our computational studies, including all figures,
were performed in Mathematica version 12.2 (Wol-
fram Research, Champaign, IL, USA); a copy of the
source code is available as supplementary material.
Establishing reference intervals: direct sampling
Defining reference individuals
Direct sampling refers to reference individuals
selected from a reference population using specific,
well-defined criteria. The reference population is
defined using criteria such that it is similar to the
patient group in aspects such as age, ethnicity and
gender: a single group of young, healthy adults is
unlikely to be as clinically appropriate as age-related
reference intervals [2]. Group comparisons in a
research context should also ensure balanced ages,
ethnicities and genders between disease groups and
control or comparison groups. Careful selection of the
reference population is important: a too-narrowly
defined population with many restrictions will have
only limited applicability. Including even a few
diseased subjects in the reference sample group, either
by a definitional oversight or misdiagnosis, may have a
marked effect on the reference interval. For example,
suppose a disease decreases an ERG measurement to
abnormal levels. If there were 100 subjects in the
reference sample group, the 2.5th percentile would be
the value from the subject with the 3rd smallest result
when using the nonparametric method (see footnote 2:
index = 0.5 ? p n = 0.5 ? (0.025 9 100) = 3). If
three subjects had the disease, the reference limit
would be set by one of the disease cases, not someone
free from disease. With two diseased subjects, the
reference limit would be the value from the free-from-
Fig. 1 Illustration of terms. Upper panel: example of the
distribution of reference values from the reference population
shown as a probability density function (idealised data,
demonstrated herein with a gamma distribution. The gamma
distribution is one of many probability distributions in an
exponential family; others include the normal (Gaussian), log-
normal and Poisson distributions. It was selected to illustrate a
skewed distribution as well as the issues associated with having
a mismatch between a fitted model and the underlying data in
parametric methods). The reference interval spans from the
lower to the upper reference limit and encloses the middle 95%
of the distribution. Lower panel: histogram of 120 random
measurements sampled from the distribution in the upper panel,
forming the reference distribution. The reference intervals and
reference limits are derived from sample measurements such as
these, along with estimates of the uncertainties of those limits
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disease subject with the smallest result, rather than
from the free-from-disease subject with the 3rd
smallest result.
For a priori and a posteriori population sampling,
criteria are applied before and after data collection,
respectively. Exclusion criteria are used to minimise
the number of subjects with non-pathology-related
changes and may differ by test and centre (Table 1). A
further list of factors known to affect ISCEV standard
parameters, i.e. potential partitioning criteria, is also
given in Table 1.
These exclusion criteria define subjects eligible for
recruitment to a reference study. For any study, ethical
approval and relevant permissions are required, and
subjects must give written, informed consent. Moni-
toring data findings and adjusting recruitment strate-
gies ensure adequate demographic and age
distributions. Partition factors and exclusion criteria
are included in a questionnaire with any additional
relevant factors to capture a minimum dataset for
recruited subjects. Specific questions relating to the
presence of or family history of ophthalmic or
neurological conditions are valuable: self-reporting,
screening or ophthalmic examination may be war-
ranted, and assessment is adapted to be suitable for
age. Further details captured at the time of testing
include test site, time of day, order of tests, person
performing the test, equipment serial numbers, proto-
col identification numbers, stimulus calibration infor-
mation, device and electrode type. Any factors that
deviate from the relevant ISCEV standard is noted,
and where the standard allows options (for example,
ERG active electrode type) or a range of variables, the
option or value chosen is noted.
Nonparametric method
The nonparametric method is the gold standard for
establishing reference limits [2]. It makes no assump-
tions about the shape of the reference distribution,
relying on only the values near the edges of the
frequency plot (Fig. 1). Data are ranked and per-
centiles calculated,2 with the minimum number of data
points, n, required to distinguish two adjacent per-





Therefore, to distinguish the 2.5th from the 5th
percentile, a minimum of n = 39 data points are
required. With this minimum number and without
using interpolation techniques, the extreme values of
the distribution become the estimated reference limits
and are therefore vulnerable to aberrant values.
Increasing the sample size reduces this vulnerability.
Precision of a reference limit is conventionally
expressed as its 90% confidence interval (CI) and can
be calculated from ranked data [25] or bootstrapping
Table 1 Exclusion criteria and partitioning factors for consideration when designing a reference data study for clinical visual
electrophysiology






Recent or current illness Refractive status
History of premature birth
History or family history of ophthalmic or neurological disease
History of retinal surgeries, recent other ocular surgeries (e.g. cataract)
Indicators of ocular disease such as high intraocular pressure, diabetes, poor cup-to-disc ratios,
poor best-corrected visual acuity
2 Percentiles are derived from a sample, as estimates of true
population percentiles, by calculating an index position of the
ranked sample data or using linear extrapolation for non-integer
indices. Index = 0.5 ? p n, where p is the percentile of interest




(see below). A sample size of 120 data points is the
smallest number that allows exact, nonparametric
calculation of the precision of each reference limit
[26] and therefore is the minimum recommended [2].
This sample size is after any outlier removal and is for
each partition (e.g. for males and for females if these
differ significantly).
Parametric method
Unlike nonparametric methods, parametric methods
use information from all the reference values, thereby
reducing uncertainty but relying on assumptions about
the shape of the underlying reference population.
Physiological measurement data seldom have a Gaus-
sian distribution, if for no other reason than Gaussians
have nonzero probability for all values, which would
include physiologically impossible negative time
delays (where the response occurs before the stimulus)
as well as mathematically impossible negative peak-
to-peak amplitudes. The central limit theorem, which
makes many statistical processes which are sums have
a Gaussian distribution, applies only to the centre and
not to the tails of a distribution which is where the
reference limits are located.
Standard tests such as Kolmogorov–Smirnov or
Anderson–Darling’s [27] can be applied to assess
normality. If acceptably normal, 95% reference limits
are defined as the sample mean ± 1.96 standard
deviations. The 90% CI of each reference limit can
be calculated as





where s is the standard deviation of the sample and n is
the number of data points [25]. This formula is an
approximation to the non-central Student’s T distri-
bution of the Lawless interval [28]. The error between
the formulae is shown in Fig. 2, where for reasonably
sized n, the difference is sufficiently small that they are
interchangeable (and Eq. 2 is much easier to calcu-
late). Because parametric tests involve more assump-
tions than nonparametric tests, they are generally more
powerful and require smaller sample sizes to reach
equivalent certainty as the nonparametric gold stan-
dard [29].
In some cases, a Gaussian distribution can be
achieved by transforming the data using logarithmic,
power function (Box-Cox), square root or other
suitable transforms [25, 27]. Limits and their confi-
dence intervals derived from transformed data are
back-transformed before use. Required sample sizes
are greater if data need to be transformed [27] (Fig. 3).
If reference limits are defined parametrically as
mean ± 1.96 standard deviations when the data do not
have a Gaussian distribution either before or after
transformation, systematic misclassification will
occur: although the parametric reference interval
may enclose 95% of reference values, it will not be
the central 95%. For example, amplitude data are
usually skewed (Fig. 3). Parametric reference limits
will misclassify, for example, ERGs with low ampli-
tudes as normal, and misclassify ERGs with large
amplitudes as supranormal (or hypernormal).
Bootstrapping techniques
Bootstrapping is useful in deriving reference intervals
because it allows inference about a population, e.g. its
distribution, from a sample. By repeatedly resampling
a dataset (with replacement), multiple, new, resampled
datasets are generated in which original values may
occur more than once, once, or not at all: the
resampled datasets will emulate the results of repeat-
ing experiments. From these resampled datasets,
bootstrap estimates of the reference limits and their
precision (90% CIs) can be calculated. This technique
improves the precision of reference limit estimation,
Fig. 2 Percentage error in Eq. 2 relative to the non-central
Student’s T distribution of the Lawless interval, as a function of
number of data points n. Equation 2 provides the confidence
intervals for the upper and lower reference limits. All four
confidence interval points are shown, although results overlap.




so that the requirement for the 90% CI of a reference
limit to be\ 0.2 of the reference interval is achieved
with smaller sample sizes than with the nonparametric
technique [30]. The bootstrapping technique is suit-
able for data which is not, and cannot be transformed
to be, Gaussian in distribution, and can be employed
for relatively small samples (n * 40) [29, 31–33].
Outliers
Measurements obtained from the reference sample
group are curated to remove outlying data points [34].
There is a trade-off between removing outliers, which
narrows the reference interval and thereby highlights
more diseased cases, and removing useful data which
thereby flags more normal cases. The emphasis is
always on retaining data.
Inspection of graphed data is a helpful process, and
data points distinctively separated from neighbouring
points are examined to establish whether they are due
to measurement error, operator or device error, subject
compliance, deviations from protocol, or non-adher-
ence to inclusion/exclusion criteria. Relying on intu-
itive insight from graphs should be used with caution;
for example, the rightmost point in Figs. 1 and 3 was a
sample from the underlying distribution and therefore
should not be classified as an outlier.
Objective techniques exist to remove any remain-
ing outlying data from a near-Gaussian distribution
(before or after transformation), for example Pierce’s
a b
c d
Fig. 3 Illustration of nonparametric (a, b) and parametric (c, d)
reference interval estimates with precision estimates (90% CI).
Data are from Fig. 1. Black vertical lines: true reference limits
of the underlying population calculated exactly by integrating
the probability density function of the continuous gamma
distribution used as the source for the sampled data. Dots:
sampled data from underlying population. Red vertical lines:
reference limits estimated from sample data using the different
methods. Grey boxes: 90% CIs of estimated reference limits.
For nonparametric estimates (a, b), CIs are wider for the longer
(right) tail of the distribution, being 29% of the reference
interval in panel a, exceeding the 20% goal so that more
measurements may be needed. Bootstrapping (1000 9 , panel
b narrows this CI from 29 to 23% of the reference interval.
Estimated limits are close to true limits. Panel c shows
parametric (mean ± 1.96 standard deviations) estimates and
their CIs. The data do not have a Gaussian distribution
(normality test fail, p\ 0.05). 90% CIs are incorrectly
symmetrical for both reference limits, and inaccurately narrow
(13% of the reference interval): the lower CI does not enclose
the true reference limit. Panel d shows parametric estimates,
performed on log-transformed data, and back-transformed for
display. Estimated limits’ 90% CIs enclose the true limits, but
the precision of longer (right) tail is 29% of the reference
interval, exceeding the 20% goal so that more measurements
may be needed. The gaps between true and estimated limits
indicate the data distribution deviates somewhat from the
assumed log-normal although the statistical test fails to reject




criterion, Grubbs’ test, and Reed/Dixon’s Q test [35].
Where the shape of the reference distribution is not
known, Tukey’s fences rejects outliers using nonpara-
metric techniques [36]. Advanced numerical tech-
niques have also been described [37]. Using Tukey’s
far outliers (three interquartile ranges from the upper
or lower quartile), for example, rejects two values per
million from a Gaussian distribution but two values
per thousand from the gamma distribution used in
Figs. 1 and 3.
Outlier detection should be performed after any
adjustments to the data are made (see sections on
Subject age (below), and transformations in the
Parametric method section (above)). For example, if
peak times increase with age and if outlier detection is
performed before adjusting values based on age,
elderly (and very young) subjects may erroneously
be more likely to be classified as outliers.
Prevention of outliers affecting estimates of age
dependence or parametric method fit parameters may
be done with robust fitting techniques [2, 32, 38].
Tukey’s biweights, instead of minimising the squared
errors between the fit and the data, perform the
minimisation iteratively after attenuating errors that
are excessively large. Trimmed means or Tukey’s
biweights can be used to estimate the mean, and the
interquartile range can be used in place of standard
deviation.
Recommended number of subjects
While no single recommended number exists, a
justified target is at least 120 subjects after outlier
removal [26]. It is always better to have more subjects
than fewer; larger numbers of subjects reduce the
uncertainty of the reference limits and also enable
finer-grained partitioning which may give tighter
reference intervals, making it more likely that diseased
subjects will be flagged to the clinician.
The key criterion for required sample size is that the
precision with which the reference limits are known
(their 90% confidence intervals or CIs) is small
relative to the biological dispersion, i.e. the reference
interval itself (Fig. 3). It is recommended that the CI of
a reference limit should be\ 0.2 of the whole
reference interval [2, 27, 29]. CIs indicate the relia-
bility of reference limits and therefore whether a test is
able to meet clinical expectations. Meeting this
criterion, especially for data at the long-tailed end of
highly skewed distributions, may be difficult to
achieve as the required sample size may be consider-
ably beyond 120 per partition when using nonpara-
metric methods. If the reference distribution is
Gaussian, meeting this criterion may require as few
as 55 subjects per partition [39].
In some instances, for example very young or
highly myopic subjects, it may not be possible to
collect sufficient reference data points. Recommen-
dations for handling small reference datasets have
been developed [40]. For sample sizes C 20 but\ 40,
robust or parametric (if appropriate) techniques should
be used; calculation of 90% CIs should only be
undertaken to illustrate the magnitude of uncertainty,
not for clinical classification as ‘indeterminate’. Data
should be presented as a histogram with median (or
mean) and minimum and maximum values stated. For
sample sizes C 10 but\ 20, values should be listed in
a ranked table with only the median (or mean)
calculated [39]. It is not recommended that reference
data from 10 or fewer subjects be reported, and
subject-based reference intervals should be considered
if so few reference subjects are available [40].
Correlation between eyes
ERGmeasurements between the right and left eyes are
correlated [18, 19, 41]. When estimating a reference
limit, there are several acceptable strategies to com-
pensate for inter-eye correlation. Data from only one
eye per subject may be used, although because the
inter-eye correlation is not perfect, information is lost.
Averaging results between eyes is not recommended,
as it erroneously reduces the effect of variability due to
recording factors such as electrode placement: no such
reduction in variability will occur during patient
testing. If all reference subjects provide data from
both eyes, using both eyes’ data will not affect the
expected values of the reference limits but will
improve their accuracy. In the limit of no correlation,
using both eyes’ data is the same as doubling the
sample size, as seen in the right panel of Fig. 4, where
no correlation (r = 0) provides the same performance
as doubling the number of subjects. In the limit of
perfect correlation, using both eyes’ data has no effect:
for example, the 10th percentile of the digits 0–9 is 1
no matter how many sets of those digits are used (and
also can be seen at the rightmost side of plots in the
right panel in Fig. 4). If only some subjects have data
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from both eyes, strategies to use all available infor-
mation become more complex. Through simulations
(Fig. 4), we found that duplicating single eye data
from subjects where only one eye was tested (making
perfectly correlated two-eye subjects), so that all
subjects have a pair of results, works well across
sample sizes and levels of correlation. The duplication
method is never worse than the using only one eye and
is better when the eyes are not perfectly correlated.
When estimating the uncertainty in reference
limits, one must also compensate for inter-eye corre-
lation, unless only data from one eye per subject were
used. We found through simulations that bootstrap-
ping subjects (not eyes) eliminate overly narrow
confidence intervals resulting from having ‘dupli-
cates’ in cases of high correlation between eyes, while
also not affecting the confidence intervals in low
correlation cases. Using generalised estimating equa-
tions [42], which estimate the correlation as a fit
parameter, may also be useful in computing the
confidence intervals.
One or two reference limits?
Typically, pathology affects electrophysiological
measures by reducing amplitude and increasing peak
times, and it has been considered that one-tailed limits
are suitable for evoked potential measures, i.e. that an
evoked potential can only be too small or too late [43].
However, in clinical visual electrophysiology, find-
ings in several pathologies contradict this. For exam-
ple, early pattern VEP P100 peak are seen in some
patients with visual pathway dysfunction [44, 45] and
supranormal VEP amplitudes are also seen in certain
conditions [46]. Whilst supranormal (or hypernormal)
full-field ERG amplitudes have been related to
pathology [47], the prevalence of extreme amplitudes
(104 out of 5000 cases) may be that expected by
chance [48]. For these reasons, the choice of con-
structing one- or two-sided reference limits should be
made for each parameter based on the likelihood of
too-early peak times or too-large amplitudes being
seen in pathological cases. Where both extremes of a
parameter are associated with pathology, the reference
interval is from the central portion of the distribution,
e.g. 2.5th to the 97.5th percentile. Where only one
extreme is associated with pathology, the reference
interval is the upper or lower portion of the distribu-
tion, and the single reference limit is the 5th or the 95th
percentile as appropriate. When using one-sided
reference limits, we propose still expressing its
uncertainty as the ratio of its 90% CI to the two-tailed
95% reference interval (2.5th–97.5th percentile)
rather than a one-tailed reference interval. The two-
tailed reference interval is numerically more favour-
able than using either of the one-tailed reference
intervals (5th–100th or 0th–95th percentile), which
Fig. 4 Uncertainty of reference limits, expressed as the ratio
(%) of the 90% confidence interval (CI) of a limit to the whole
reference interval (RI), as a function of inter-eye correlation.
Three methods for handling correlation between eyes are
shown: use one eye per subject (solid lines); use all available
eyes as independent samples (dashed lines); and, for subjects
with data from only one eye, duplicate the point so that all
subjects have data from two eyes, then use all eyes as
independent samples (dotted lines). Right panel: all subjects
have results from both eyes. Left panel: 75% of subjects have
results from both eyes and 25% have results only for one eye.
For each correlation coefficient and number of subjects, samples
of correlated Gaussian random variables were taken and the
lower reference limit was estimated using the nonparametric
method. The process was repeated 1,000,000 times for each
condition. n: number of subjects
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depends on the most extreme value measured and
therefore does not converge with increasing n.
Partitioning
The effect of demographic variables, such as gender,
race or age (see Table 1), on any visual electrophys-
iological parameter can be gathered from the litera-
ture. Where a demographic affects a parameter such
that there is both a statistically significant and a
clinically meaningful difference between subgroup
average values, partitions are made to create separate
subgroups. One rule of thumb suggests separate
reference ranges are not required unless subgroup
averages differ by[ 25% of the 95% reference range
of the combined group [49]; a more stringent require-
ment of * 15% has also been suggested [50]. An
alternative metric requires separate partitions if[ 4%
of reference data points from one subclass fall outside
the reference limits for all groups combined [50]. A
further recommendation requires separate subgroup
reference ranges if the ratio of subgroup standard
deviations is 1.5 or greater, regardless of any differ-
ence in subgroup means [50]. Given the challenges of
recruiting and testing sufficient subjects per partition,
limiting the number of partitions is advisable.
Subject age
Unlike some demographic variables, age is a contin-
uous value. Partitioning age into decades or some
other grouping leads to artefacts at the group bound-
aries, where identical test results on the day before and
the day of a subject’s birthday may switch classifica-
tion from abnormal to normal (or vice versa) as the
subject ages into a new age partition. Having more age
groups reduces the changes in reference interval
between adjacent groups, but requires more reference
subjects.
The majority of visual electrophysiology parame-
ters change during infancy and childhood, and to a
lesser extent, in the elderly. For example, the P100 of
the pattern reversal VEP is strongly dependent on age
over the first year of life, being slower in younger
babies: pooling infants and toddlers together in a
reference dataset will create reference intervals which
are too wide to detect abnormalities in toddler-aged
patients [51]. Studies of age-related changes generally
employ a cross-sectional study design where each
reference subject provides data at a single age, with
ages suitably sampled for robust centile estimation
[52–54]. Given the onerous nature of testing small
children, smaller sample sizes are likely per age group,
which makes estimates vulnerable to extreme obser-
vations; optimal reference sample groups may require
as many as 500 reference subjects [55].
Compensating for age with a continuous function
(e.g. linear correction) may be preferable as it keeps all
the subjects in the same partition. Robust curve fitting
is useful in this process so that age compensation can
happen before outlier removal [56, 57]. With many
subjects in the reference distribution, the upper and
lower reference limits can be separately fitted so that
the width of the reference interval can change with age
as well.
Establishing reference intervals: indirect sampling
Where direct sampling of a reference population is not
possible, reference intervals can be derived from
patient data [58, 59], referred to as indirect sampling.
Since patients often undergo visual electrophysiology
tests to have a disease excluded, many do indeed have
normal test results. It is therefore possible to extract an
estimated ‘health-related’ sub-population from patient
databases, although reference intervals derived this
way may not reflect the general population [60, 61].
Discussion of indirect sampling techniques is beyond
the scope of this work, but readers are referred to
techniques described elsewhere, based on removal of
outliers, systematic removal of subjects with certain
clinical factors [62], removal of repeat measures, and
statistical derivation of two sub-samples, one of which
aims to reflect a ‘health-related’ sub-population
[61, 63–65]. Data mining applications make such
analyses of large datasets feasible [66–68].
Transference of a reference interval
Establishing reliable reference intervals is time-con-
suming and costly. Where possible, reference intervals
already established elsewhere should be used, provid-
ing quality conditions can be met. Transference of a
reference value is the process of adapting a previously
established reference interval to a new or updated test
technique or test centre [2, 32, 69]. As an example, a
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centre previously established an ERG reference inter-
val based on the 2004 Standard [70] using a
2.0 cdsm-2 flash, but wished to update their ERG
test protocol to comply with the current stipulation of
3.0 cdsm-2 [12]. As another example, one may want
to transfer reference data taken with one electrode type
to another electrode type.
Transference of a reference interval involves com-
paring results from the same subjects tested with both
methods, which is the subject of an international
guideline in clinical laboratories [2, 71] (Fig. 5).
Measure at least 40 subjects using both the old and
new test methods. If the results have high correlation
(r2  0:7) [72], a slope near one, and small offset,
existing reference intervals can be used with the new
test method. If the correlation is high, but the slope or
offset are clinically significant, reference limits can be
mathematically adjusted using values from the corre-
lation equation. The measurements should span a wide
range, and the magnitude of any offset (intercept)
should be small relative to the data range and to the
reference interval. Both diseased subjects and subjects
free from disease can be used.
If a centre wishes to adopt a reference interval
established elsewhere, visual electrophysiology has a
great advantage over clinical laboratories, as the
establishment of ISCEV standards has produced
tightly defined stimulus, acquisition and analysis
parameters, which results in very low intra-individual
variation, as established for the pattern VEP [73] and
the full-field ERG [74], even when different equip-
ments are used. This greatly increases confidence in
the possibility of transferring reference intervals.
Verification (or validation) of a reference interval
Verification of a reference value is the process of
ensuring that a reference interval established else-
where can be adopted locally with reasonable confi-
dence [2, 69, 72] (Fig. 5). This might typically occur
when a centre wishes to use a manufacturer’s own,
built-in reference data or another centre’s reference
data. It should also be undertaken as part of transfer-
ence of reference intervals.
Initial verification entails documented assessment
of the original reference dataset, i.e. demographic
variables and method of estimating the reference
limits, and of the original test procedures: if these
factors are subjectively judged to be comparable with
the adopting centre’s test methods and patient popu-
lation, then adoption is validated.
Further verification may be necessary, particularly
if not all required details of the reference interval are
available. The adopting centre recruits 20 local
reference subjects who satisfy exclusion and partition
criteria: if no more than two reference data points fall
outside the primary reference interval, that interval
can be considered acceptable for local use. If three or
four data points fall outside the primary reference
a
b




range, a further 20 local subjects should be recruited
and tested; if no more than two reference data points
from this second local sample group fall outside the
primary reference interval, the interval can be consid-
ered acceptable for local use. Otherwise, a re-exam-
ination of test protocols should be considered, along
with the possibility that the local patient population is
substantially different to the reference subjects con-
tributing to the primary reference sample.
This simple check is vulnerable to error for skewed
distributions or variance differences between primary
and local samples. If the full primary reference dataset
is available, comparisons using Mann–Whitney U,
Siegel–Tukey or Kolmogorov–Smirnov are more
sensitive and specific [2]. For greater accuracy in
deciding the acceptability of a primary reference
dataset, for example where there is a particular local
need for accuracy, larger numbers of local reference
subjects can be tested [71].
Interpreting serial measurements: subject-based
reference values
Population-based reference intervals, as discussed so
far, are primarily used for a single, diagnostic assess-
ment, for case-finding, and for screening. However,
their high inter-individual variability means they may
not be sensitive to changes within a patient over time:
an individual could show significant worsening of a
parameter even though it remains well within the
reference interval [41, 75, 76]. In some developed
economies, healthcare is increasingly devoted to
management of disease, with proliferation of serial
measurements on patients. In such cases, subject-
based reference values from longitudinal data may be
more useful than cross-sectional population-based
reference values to decide whether a parameter has
changed by a clinically meaningful amount—the
‘delta check’. The size of the change should exceed
that expected to be due to inherent sources of
variability such as acquisition or stimulus changes,
electrode positioning, and to the individual’s biolog-
ical changes, some of which can be minimised by
standardised protocols related to time of day, pupil
diameter and so forth.
The critical change size (or critical difference) is











where z is the z-statistic, CV is the coefficient of
variation of replicates and SD is the standard deviation
of replicates. Generally, standard deviations should be
used for times (variability expressed inms), while CVs
should be used for amplitudes (variability expressed in
percent changes). The z-statistic is conventionally
taken to be 1.96, giving a 5% probability of a false
positive. Larger z values increase the size of the
change required to be classified as a significant change
(the RC), thus decreasing the false-positive rate while
increasing the false-negative rate [78]. If z = 1.96,
Eq. 3 simplifies to RC = 2.77 9 CV or RC = 2.77 9
SD. With data from multiple subjects, each with the
same number of replicates, the average CV or SD is
used. If the number of replicates differs between
subjects, a weighted average is used to account for the








where ki is the number of replicates for the ith subject,
si is the standard deviation for the ith subject, and N is
the total number of subjects. The CV is defined
analogously. When computing the RC, data from each
eye should not be combined but treated as separate
‘subjects’. Combining data from both eyes in calcu-
lating a standard deviation will artificially increase the
standard deviation in cases where expected value of
the two eyes is not the same (e.g. unilateral disease).
See simulations in the supplementary material for
additional evidence for treating each eye separately.
Uncertainty of the RC can be computed, for example,
by using bootstrapping as described.
The RC can be measured with as few as eight
subjects [79]. Clinically meaningful flash VEP
changes [80] and ERG changes have been established
for patients with [41, 81–84] and without retinal
disease [81, 85]; RCs established from stable but
diseased patients may sometimes be appropriate.
Multidimensional reference region
Visual electrophysiology data are naturally bi-variate
(e.g. the pattern ERG P50 has both an amplitude and a
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peak time) with both data portions being related to
some degree, being derived from the same part of the
organ system. Multiple further related measures are
often captured at the same recording (e.g. pattern ERG
N95 parameters) and even more during a test session,
which may also record full-field ERGs, multifocal
ERGs and other indicated tests. They therefore
naturally lend themselves to multivariate reference
regions rather than multiple univariate reference
intervals as have been discussed so far, thereby
reducing the risk of false-positive findings. Despite
their suitability for scoring multiple tests assessing the
same organ system, multivariate reference regions are
only slowly gaining traction as a diagnostic tool
[86–88], perhaps because of difficulties with clinical
interpretation or the relatively complexmaths required
[89, 90].
Clinical interpretation
Relation between reference intervals, clinical
decision limits and disease detection
Measurements falling within the reference interval are
consistent with the reference population, i.e. people
with normal vision, and are classified as normal.
Normal measurements do not guarantee the patient is
disease-free; for example, the patient may have a
disease that does not affect that measurement. Mea-
surements outside the reference interval are not
consistent with the reference population and are
classified as abnormal or atypical. Patients with
atypical results can be examined more closely or
more frequently with more concern for cases where
the results are far from the reference limits in a
direction associated with disease. Reference limits
cannot be used to tell which disease a patient might
have, but they can highlight cases where some disease
is suspected.
Measurements falling within the CI of either the
upper or lower reference limit may be considered
‘indeterminate’ [91] to some extent. For small refer-
ence samples, many patient parameters will fall in
these indeterminate zones. No clear guidance exists on
how to handle this, and it may simply be advisable to
be aware of the size of reference limits’ CIs when
reporting and interpreting clinical visual electrophys-
iology recordings.
For serial (or longitudinal) testing, a measurement
outside the repeatability coefficient (RC) indicates that
patient’s result has changed, either improving or
worsening depending on what is known about the way
a particular disease affects the measurement.
Clinical decision limits, by contrast, classify
patients as diseased or healthy. They are determined
using data from diseased subjects as well as healthy
subjects and consider the balance of test sensitivity
and specificity. For example, the World Health
Organization recommends a clinical decision limit of
glycated haemoglobin (HbA1c) C 6.5% to classify
patients as having diabetes [92].
If a 95% reference interval is used as a clinical
decision limit for detecting a disease, the test speci-
ficity (probability a healthy subject is classified as
healthy) is 95%, because that is the proportion of
reference subjects enclosed by the 95% reference
interval. Reference intervals cannot be used to classify
a patient as having a particular disease because the
disease’s influence on the measurement is not used
when constructing the reference intervals (in fact, no
diseased subjects are used in making reference inter-
vals). In other words, 95% reference intervals used as
clinical decision limits have no impact on test
sensitivity (probability a diseased subject is classified
as diseased).
Adjusting for multiple measurements
The use of a 95% reference range means that any
single parameter has a one in 20 chance of being
classified as abnormal when no abnormality exits, so
reporting multiple parameters from multiple tests
(n parameters total) carries an increasing risk
(1–0.95n) [20] of false-positive findings (if all n pa-
rameters are uncorrelated with each other) and may
require to be adjusted for simultaneous statistical
inference [19]. Useful test interpretation, following
factual classification of each parameter can utilise
understanding of the origin and interaction between
parameters to mitigate such risks. For example, a
borderline-small ERG a-wave may be of concern in
the face of an abnormally delayed a-wave peak time or
an abnormally small b-wave, but would be of less




Clinical visual electrophysiology has long established
and highly standardised tests, which appear to have
low within-subject variability. Current ISCEV stan-
dards indicate that each centre should establish its own
reference data; however, undertaking this process
adequately is onerous and likely not to be feasible for
all centres. Transferring and verifying reference
datasets from elsewhere, with due care to quality
measures, offer the possibility of sharing high-quality,
large reference datasets. It also allows high-quality
legacy reference data to continue to be used even when
standards are updated. Such initiatives have success-
fully been undertaken in other clinical areas with the
goal of harmonising reference limits, to the great
benefit of patients [93, 94].
Clinical electrophysiology has advantages over
imaging techniques, because of its consistency due
to international standards [9–13] and because of its
generation of objective, quantitative data that can be
robustly classified using reference data. This paper
describes methods of creating reference limits either
by establishing them de novo or by transferring or
validating limits acquired elsewhere. Our emphasis
has been on clinical electrophysiology of vision;
however, these methods are also valid for other
quantitative clinical measurements on bilateral sys-
tems where intra-subject correlation needs to be
considered. Good quality reference limits minimise
false-positive and false-negative results, thereby max-
imising the clinical utility and patient benefit. Quality
indicators include using appropriately sized reference
datasets with appropriate numerical handling for
reporting; using subject-based reference limits where
appropriate; and limiting tests for each patient to only
those which are clinically indicated, independent and
highly discriminating.
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